Comments
GlaxoSmithKline Consumer Healthcare Ltd has posted a net profit of ₹ 219 crore for the quarter ended September 30, up about 37 per cent against ₹ 160.29 crore in the corresponding quarter previous fiscal. Though the company saw marginal increase in gross sales of 5 per cent to ₹ 1,191 crore. “Our financial performance has been consistent which exhibits consumer confidence in our brands…We have observed that the inflation rates have been low in the past few quarters and consumer confidence is gradually on the rise,” said Manoj Kumar, Managing Director, GlaxoSmithKline Consumer Healthcare Ltd.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.